1 / 43

Why should I lose time to send a report of adverse drug reactions?

Why should I lose time to send a report of adverse drug reactions?. The voluntary ADR reporting was developed to detect rare, serious, unexpected adverse drug, mainly type B, reactions over 40 years ago. . What is an adverse drug reaction?.

buthainah
Télécharger la présentation

Why should I lose time to send a report of adverse drug reactions?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Why should I lose time to send a report of adverse drug reactions?

  2. The voluntary ADR reporting was developed to detect rare, serious, unexpected adverse drug, mainly type B, reactions over 40 years ago.

  3. What is an adverse drug reaction? A response to a drug that is noxious and unintended and occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for modification of physiological function WHO, 1972

  4. Pharmacovigilance Monitoring and analysis of spontaneous adverse drug reactions WHO-CC: Uppsala Monitoring Centre, Sweden

  5. WHO-CC Uppsala Monitoring Centre Collects volountary reports of Adveres Drug Reactions from all over the world

  6. WHO Drug Monitoring Programme

  7. WHO WHO Collaborating Centre for International Drug Monitoring - The Uppsala Monitoring Centre > 4 million reports

  8. SWEDIS Swedish Drug Information System 1965-2007 105.000 ADR reports with causality assessment

  9. Six Health Care Regions - each with a medical school Northern Region Umeå Uppsala Region Uppsala Western Region Gothenburg Stockholm Region Stockholm Southern Region Lund and Malmö South-east Region Linköping

  10. Causality Assessment Known reaction Time-relasionship Cannot be explained by the underlying diseases or medications

  11. I stopped taking the medicine because I prefer the original disease to the side effects !

  12. Causality Assessment Known reaction Time-relasionship Cannot be explained by the underlying diseases or medications Dissapperar at dechallenge Reappear at Rechallenge

  13. ADR reports in Sweden

  14. Pharmacovigilance from a public health point of view

  15. Bergman U, Wiholm B-E. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981;20:193 200.

  16. Bergman U, Wiholm B-E. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981;20:193 200. Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:178-184

  17. Swedish ADR hospitalization studies 1.      Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. Läkartidningen 1978;75:959-60. 2.      Bergman U, Wiholm B-E. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981;20:193 200. 3.      Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47:5349-53. 4.      Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A et al. Adverse drug reaction as a cause for admissions to a department of internal medicine. Pharmacoepidemol Drug Safe 2002;11:65-72. 5.      Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:178-184

  18. ADR hospitalizations in % 1.Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. 9 % Läkartidningen 1978;75:959-60. 2.Bergman U, Wiholm B-E. Drug-related problems causing admission 6 % to a medical clinic. Eur J Clin Pharmacol 1981;20:193 200. 3.Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar 14 % leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47:5349-53. 4.Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A. Adverse drug reaction as a cause for admissions to a department of internal 12 % medicine. Pharmacoepidemol Drug Safe 2002;11:65-72. 5.Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records 11 % and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:178-184

  19. Mean AGE in ADR hospitalizations 1.Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. 71 year Läkartidningen 1978;75:959-60. 2.Bergman U, Wiholm B-E. Drug-related problems causing admission 66 year to a medical clinic. Eur J Clin Pharmacol 1981;20:193 200. 3.Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar 77 year leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47:5349-53. 4.Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A. Adverse drug reaction as a cause for admissions to a department of internal 74 year medicine. Pharmacoepidemol Drug Safe 2002;11:65-72. 5.Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records 72 year and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:178-184

  20. Number of drugs/patient with ADR hospitalizations 1.Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. 3,7 Läkartidningen 1978;75:959-60. 2.Bergman U, Wiholm B-E. Drug-related problems causing admission 3,5 to a medical clinic. Eur J Clin Pharmacol 1981;20:193 200. 3.Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar 6,2 leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47:5349-53. 4.Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A. Adverse drug reaction as a cause for admissions to a department of internal 7 medicine. Pharmacoepidemol Drug Safe 2002;11:65-72. 5.Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records 8,3 and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:178-184

  21. % phararmacological (typ A) ADRs 1.Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. >75 % Läkartidningen 1978;75:959-60. 2.Bergman U, Wiholm B-E. Drug-related problems causing admission >75 % to a medical clinic. Eur J Clin Pharmacol 1981;20:193 200. 3.Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar 100 % leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47:5349-53. 4.Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A. Adverse drug reaction as a cause for admissions to a department of internal 91 % medicine. Pharmacoepidemol Drug Safe 2002;11:65-72. 5.Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records 89 % and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:178-184

  22. In summary: ADRs in 2000 vs 1970s % more ADR hospitalizations More elderly patients More drugs per patient Pharmacologcal reactions (type A) dominats completely

  23. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. British Medical Journal 2004;329;15-9 Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Kevin Park B and Breckenridge AM.

  24. Types of ADRs • Type A • Predictable from pharmacology of the drug, dose-dependent and preventable • 95% • Type B • Bizzare, unpredictable from known pharmacology, and no dose-dependency • 5% • Pirmohamed M. et al. Br Med J 329:15-19 (2004)

  25. Types of ADRs • Type A • Predictable from pharmacology of the drug, dose-dependent and preventable • 95% • Type B • Bizzare, unpredictable from known pharmacology, and no dose-dependency • 5% ____________________________________ • 76% of patients were 65 years or over • Pirmohamed M. et al. Br Med J 329:15-19 (2004)

  26. How Many ADRs Were Avoidable? Definitely avoidable 8.6% Possibly avoidable 63.1% Not avoidable 28.1% 72 % of ADRs were definitely or possibly avoidable • Pirmohamed M. et al. Br Med J 329:15-19 (2004)

  27. Importance for Health care provider Industry and Regulatory Agency Type A Type B Adverse Drug Reactions

  28. Keep in mind the origin • Advancement in safety heavily relies on reporting of safety events by health care professionals

  29. Take Home messages: Adverse Drug Reactions- ADRs Spontaneous ADR monitoring is basis for Pharmacovigilance Pharmacological ADRs is a matter for the local health care provider – quality of care An area for Clinical Pharmacology

  30. Take Home messages: Adverse Drug Reaction- a Differential diagnosis An ADR diagnosis: (a minimum an ICD-10 Y 57.9 Ogynnsam effekt av drog eller läkemedel i terapeutiskt bru Submitt an ADR report

  31. Thank you for staying till the end!

  32. Time for Questions & Answeres If you don’t ask stupid question You remain stupid Alvan Feinstein

  33. Pharmacovigilance The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. Source: The Importance of Pharmacovigilance, WHO 2002

  34. Causality Assessment Certain Probable Possible Unlikely Unclassifiable

More Related